Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-11-01

Clinical Trial Update: The Duration of the Suppressive Effects of Desloratadine on Allergen Prick Tests After Discontinuation (P04441) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial updating the duration of suppressive effects of desloratadine on allergen prick tests after discontinuation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Desloratadine (desloratadine)

Snippet

Sponsor: Organon and Co | Conditions: Hypersensitivity | Phase 4 | Status: COMPLETED | Results posted: 2010-11-01